Purdue Settles OxyContin Patent Spat With Apotex

Law360, New York (October 27, 2009, 3:46 PM EDT) -- Purdue Pharma LP has resolved a patent dispute with Apotex Inc. that was tied into the multidistrict litigation alleging Purdue engaged in sham patent infringement litigation to keep generic companies from making copycat versions of painkiller OxyContin.

Judge Sidney H. Stein of the U.S. District Court for the Southern District of New York on Friday signed off on a consent order between Purdue and Apotex, in which the companies agreed to a settlement and the generic company acknowledged that its abbreviated new drug application, if approved,...
To view the full article, register now.